The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare condition that can ultimately lead to right heart failure and death. In this study we estimated the health care costs and resource utilization associated with PAH in a large US managed care health plan. METHODS: Subjects with claims-based e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikirica, Mirko, Iorga, Serban R, Bancroft, Tim, Potash, Jesse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301626/
https://www.ncbi.nlm.nih.gov/pubmed/25539602
http://dx.doi.org/10.1186/s12913-014-0676-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301626/
https://www.ncbi.nlm.nih.gov/pubmed/25539602
http://dx.doi.org/10.1186/s12913-014-0676-0

Ejemplares similares